<DOC>
	<DOCNO>NCT00041509</DOCNO>
	<brief_summary>The purpose study gain additional safety information well determine study drug give patient undergone total hip replacement surgery , whether study drug effective preventing late deep vein thrombosis ( blood clot legs ) pulmonary embolism ( blood clot lung ) .</brief_summary>
	<brief_title>ThromboEmbolism Prevention Efficacy Safety Trial ( TEMPEST )</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>Patients schedule primary elective unilateral total hip arthroplasty ( i.e . first time hip replace operative side ) . Patients give write informed consent participate study . Patients contraindication contrast venography Patients increase risk bleeding . Patients predefined risk prethrombotic episode history thrombophilia . Other inclusion exclusion criterion determine physician study sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>venous thromboembolism</keyword>
	<keyword>thromboembolism</keyword>
	<keyword>pulmonary embolism</keyword>
	<keyword>deep vein thrombosis</keyword>
</DOC>